CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

627 indexed citations
published 1998
Authors
Maarit Sarlomo‐RikalaAlbert J. KovatichMarkku Miettinen
Journal
PubMed

In The Last Decade

doi.org/w67910192 →

Countries where authors are citing CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

Specialization
Citations

This map shows the geographic impact of CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. more than expected).

Fields of papers citing CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34..

About CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

This paper, published in 1998, received 627 indexed citations . Written by Maarit Sarlomo‐Rikala, Albert J. Kovatich and Markku Miettinen covering the research area of Gastroenterology. It is primarily cited by scholars working on Gastroenterology (523 citations), Pulmonary and Respiratory Medicine (436 citations) and Surgery (325 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w67910192.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Rice Domestication by Reducing ShatteringBreakdown of academic impact, for the paper LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL ReceptorBreakdown of academic impact, for the paper Proton pump inhibitors alter the composition of the gut microbiotaBreakdown of academic impact, for the paper Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill PatientsBreakdown of academic impact, for the paper The health care data guide: learning from data for improvementBreakdown of academic impact, for the paper Glutamate triggers long-distance, calcium-based plant defense signalingBreakdown of academic impact, for the paper Chromium-ruthenium oxide solid solution electrocatalyst for highly efficient oxygen evolution reaction in acidic mediaBreakdown of academic impact, for the paper OrthoVenn2: a web server for whole-genome comparison and annotation of orthologous clusters across multiple speciesBreakdown of academic impact, for the paper A critical review of the pseudopotential multiphase lattice Boltzmann model: Methods and applicationsBreakdown of academic impact, for the paper Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Rankless by CCL
2026